Clinical Trials Directory

Trials / Completed

CompletedNCT05259293

Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care

Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care: a Retrospective Study in 6 Centers

Status
Completed
Phase
Study type
Observational
Enrollment
243 (actual)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The number of lung biopsies has increased steadily in recent years. Pneumothorax is the most common complication of a lung biopsy and can occur during the procedure, immediately after the procedure or within a few hours (delayed pneumothorax). The incidence of pneumothorax in the literature is very different from one study to another: it has been reported to be from 9 to 54% in patients undergoing percutaneous transthoracic needle biopsy. This difference of incidence could be explained by the absence of consensus for the definition of an iatrogenic pneumothorax. The characteristics of pneumothorax and the management of patients with iatrogenic pneumothorax will be evaluated in different centres in a retrospective manner. This study will contribute to refining the criteria for defining pneumothorax occurring during lung biopsy and will provide a better understanding of the condition and its management.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention - retrospective studyThis is a retrospective study. No intervention.

Timeline

Start date
2021-12-09
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2022-02-28
Last updated
2024-09-19

Locations

6 sites across 3 countries: France, Ireland, United Kingdom

Source: ClinicalTrials.gov record NCT05259293. Inclusion in this directory is not an endorsement.